IP Library Granted Patent US 10,894,858
Granted Patent B2
US 10,894,858 · App. 16/878,658 · Granted Jan 19, 2021

Radiation curable compositions for coating optical fiber with enhanced high-speed processability

Inventor: Johan Franz Gradus Antonius Jansen (Echt, NL)
Assignee: DSM IP ASSETS B.V.
C08G18/765C08F2/48C08F290/147C08G18/3206C08G18/3215C08G18/73C08G18/753C08G18/7621C08G18/7642C08K5/101
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,894,858
App. No.
16/878,658
Granted
Jan 19, 2021
Kind
B2
Abstract

Radiation curable compositions for coating optical fibers are disclosed herein. In an embodiment, a radiation curable composition includes a reactive oligomer component, wherein a portion of the polymerizable groups of the reactive oligomer component include methacrylate groups; a reactive diluent monomer component, wherein a portion of the polymerizable groups of the reactive diluent monomer component include acrylate groups, acrylamide groups, or N-vinyl amide groups, or combinations thereof; a photoinitiator component, and an optional additive component. Also described are methods of coating the radiation curable compositions elsewhere described, and the fiber optic coatings and cables resulting therefrom.

Claims (55)

1. A radiation curable composition for coating an optical fiber comprising:

a reactive oligomer component comprising at least one reactive urethane oligomer comprising a polymerizable group;

wherein at least 20% of a molar fraction of the polymerizable groups in the reactive oligomer component consist of methacrylate groups;

a reactive diluent monomer component comprising reactive diluent monomers having at least one polymerizable group that is able to (co)polymerize with the polymerizable group(s) of the reactive oligomer component; wherein the reactive diluent monomer component comprises a monofunctional acrylate monomer;

wherein at least 50% of a molar fraction of the polymerizable groups of the reactive diluent monomer component consist of acrylate groups, acrylamide groups, N-vinyl amide groups, or mixtures thereof;

a photoinitiator component; and

optionally, an additive component.

2. The radiation curable composition of the previous claim, wherein the reactive urethane oligomer comprises a reaction product of

a polyol compound;

a diisocyanate compound; and

a hydroxyl-functional compound having at least one methacryloyl group.

3. The radiation curable composition according to claim 1 , wherein the reactive urethane oligomer and/or the reactive oligomer component possess a number average molecular weight (Mn) from 6000 g/mol to 20,000 g/mol; wherein Mn is determined according to an SEC method using a triple detector array as described elsewhere herein.

4. The radiation curable composition according to claim 1 , wherein the reactive diluent monomer component comprises-monofunctional acrylate monomers possessing an Mn, theo or an Mn from 86 g/mol to 800 g/mol.

5. The radiation curable composition according to claim 2 , wherein the reactive oligomer component comprises difunctional reactive oligomers.

6. The radiation curable composition according to claim 2 , wherein the hydroxyl-functional compound having at least one methacryloyl group comprises two or greater than two methacryloyl groups.

7. The radiation curable composition of claim 6 , wherein the reactive oligomer comprises, in at least two different locations, the reaction product of a hydroxyl-functional compound possessing two or greater than two methacryloyl groups.

8. The radiation curable composition according to claim 6 , wherein the reactive oligomer component comprises trifunctional and/or tetrafunctional reactive oligomers.

9. The radiation curable composition according to claim 6 , wherein the hydroxyl-functional compound having two or greater than two methacryloyl groups comprises 1,2-glycerol dimethacrylate, 1,3-glycerol dimethacrylate, or combinations thereof.

10. The radiation curable composition according to claim 1 , wherein at least one polymerizable group is a polymerizable backbone group.

11. The radiation curable composition according to claim 1 , wherein the hydroxyl-functional compound having at least one methacryloyl group comprises 2-hydroxyethyl methacrylate, caprolactone 2-(methacryloyloxy)ethyl ester, or glycerol monomethacrylate, or combinations thereof.

12. The radiation curable composition according to claim 1 , wherein the reactive oligomer comprises a plurality of polymerizable groups, wherein the polymerizable groups comprise polymerizable endgroups and polymerizable backbone groups.

13. The radiation curable composition according to claim 12 , wherein the reactive oligomer component comprises pentafunctional reactive oligomers.

14. The radiation curable composition according to claim 1 , wherein, by molar fraction, at least 30% of the polymerizable groups of the reactive oligomer component consist of methacrylate groups.

15. The radiation curable composition according to claim 1 , wherein the polymerizable groups of the reactive oligomer component consist of or consist essentially of methacrylate groups.

16. The radiation curable composition according to claim 1 , wherein the polymerizable groups of the reactive diluent monomer component consist of or consist essentially of acrylate groups.

17. The radiation curable composition according to claim 1 , wherein a molar fraction of methacrylate groups present in the entire composition to a total amount of polymerizable groups present in the entire composition is from 2% to 16%.

18. The radiation curable composition according to claim 17 , wherein a molar ratio of acrylate groups to methacrylate groups in the entire composition is from 4:1 to 50:1.

19. The radiation curable composition according to claim 2 , wherein, relative to the entire weight of the composition,

the reactive oligomer component is present in an amount from 20 wt. % to 95 wt. %;

the reactive diluent monomer component is present in an amount from 4 wt. % to 75 wt. %;

the photoinitiator is present in an amount from 0.25 wt. % to 7 wt. %; and

the additives are present in an amount from 0 wt. % to 50 wt. %.

20. The radiation curable composition according to claim 19 , wherein at least one of conditions (a), (b), (c), or (d) applies:

(a) the polyol compound comprises a polyether, polyester, polycarbonate, polyamide, polycaprolactone, or acrylic moiety;

(b) the diisocyanate compound comprises isophorone diisocyanate, 2,4-isomer toluene diisocyanate, 2,4- and/or 4,4′-methylenedicyclohexyl diisocyanate, methylenediphenyl diisocyanate, tetramethylxylene diisocyanate, (hydrogenated) xylylene diisocyanate, 1,5-pentane diisocyanate, 2,2,4-trimethyl-hexamethylene diisocyanate, 2,4,4-trimethyl-hexamethylene diisocyanate, or hexamethylene diisocyanate, or combinations thereof;

(c) the hydroxyl-functional compound having at least one methacryloyl group is a methacrylate compound, and comprises 2-hydroxyethyl methacrylate, caprolactone 2-(methacryloyloxy)ethyl ester, or combinations thereof; and/or

(d) the compound having a hydroxyl group and no polymerizable group comprises n-butanol, 2-ethyl hexanol, benzyl alcohol, or combinations thereof.

21. The radiation curable composition according to claim 19 , wherein the reactive diluent monomer component comprises 2-ethylhexyl acrylate, 2-phenoxyethyl acrylate, 2-(2-ethoxyethoxy)ethyl acrylate, n-vinyl pyrrolidone, acryloyl morpholine, dimethylacryl-amide, n-vinylcaprolactam, ethoxylated 2-phenoxy ethyl acrylate, 4-hydroxy butyl acrylate, lauryl acrylate, isobornyl acrylate, caprolactone acrylate, isodecyl acrylate, or ethoxylated nonylphenol acrylate, or mixtures thereof.

22. The radiation curable composition according to claim 19 , wherein the photoinitiator comprises, consists of, or consists essentially of 4-methyl benzophenone, 2,4,6-trimethyl benzophenone, dimethoxybenzophenone, 1-hydroxycyclohexyl phenyl ketone, phenyl(1-hydroxyisopropyl)ketone, 2-hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-methyl-1-propanone, and 4-isopropylphenyl(1-hydroxyisopropyl)ketone, benzil dimethyl ketal, oligo-[2-hydroxy-2-methyl-1-[4-(1-methylvinyl)phenyl]propanone]; 2,4,6-trimethylbenzoyl diphenylphosphine oxide, 2,4,6-trimethylbenzoyl phenyl, bis(2,4,6-trimethylbenzoyl)-phenylphosphineoxide, 2-methyl-1-[4-(methylthio)phenyl]-2-morpholinopropanone-1, 2-benzyl-2-(dimethylamino)-1-[4-(4-morpholinyl)phenyl]-1-butanone, 2-dimethylamino-2-(4-methyl-benzyl)-1-(4-morpholin-4-yl-phenyl)-butan-1-one, 4-benzoyl-4′-methyl diphenyl sulphide, 4,4′-bis(diethylamino)benzophenone, or 4,4′-bis(N,N-dimethylamino)benzophenone (Michler's ketone).

23. The radiation curable composition according to claim 19 , wherein the additives comprise an adhesion promoter.

24. The radiation curable composition according to claim 23 , wherein the adhesion promoter comprises mercaptopropyltrimethoxysilane, trimethoxysilyl propyl acrylate, tetraethoxysilane, or 3 trimethoxysilyl propane-1-thiol.

25. The radiation curable composition according to claim 19 , wherein the additives comprise an antioxidant, a polymerization inhibitor, a photosensitizer, a carrier surfactant, a tackifier, a catalyst, a stabilizer, a surface agent, and/or an optical brightener.

26. The radiation curable composition according to claim 1 , wherein the composition possesses a T 30%, modulus max value from 0.3 to 1.5 seconds, wherein the T 30%, modulus max value is measured by procedures as described herein, and/or wherein the composition possesses a maximum modulus (G′) value of less than 0.5 MPa, wherein the G′ value is measured by procedures as described herein.

27. The radiation curable composition according to claim 1 , wherein in a copolymerization between the compound having at least one methacryloyl group and 2-hydroxyethyl acrylate (HEA),

a self-reactivity ratio of the compound having at least one methacryloyl group (R 1 ) is between 1 and 5, or between 1.4 and 3.5;

wherein, R 1 is determined according to multivariate analysis using the infrared spectra of the copolymer input compounds.

28. The radiation curable composition according to claim 27 , wherein a reactivity ratio of the compound having at least one methacryloyl group with HEA (R 2 ) is from 0.1 to 0.5, or from about 0.15 to about 0.35;

wherein, R 2 is determined according to multivariate analysis using the infrared spectra of the copolymer input compounds.

29. The radiation curable composition according to claim 28 , wherein

R

1

R

2

is from 3 to 11.

30. The radiation curable composition according to claim 1 , wherein, by molar fraction, at least 50% of the polymerizable groups of the reactive oligomer component consist of methacrylate groups; and at least 90% of the molar fraction of the polymerizable groups of the reactive diluent monomer component consist of acrylate groups, acrylamide groups, N-vinyl amide groups, or mixtures thereof.

Assignments (5)
CHANGE OF CORPORATE ADDRESS Recorded Mar 30, 2022
From: COVESTRO (NETHERLANDS) B.V.
To: COVESTRO (NETHERLANDS) B.V.
Reel/Frame 059546/0570 →
CHANGE OF NAME Recorded Jul 2, 2021
From: MS HOLDING B.V.
To: COVESTRO (NETHERLANDS) B.V.
Reel/Frame 056756/0513 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2021
From: DSM IP ASSETS B.V.
To: MS HOLDING B.V.
Reel/Frame 056726/0106 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2020
From: JANSEN, JOHAN FRANZ GRADUS ANTONIUS
To: DSM IP ASSETS B.V.
Reel/Frame 054126/0778 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2020
From: JANSEN, JOHAN FRANZ GRADUS ANTONIUS
To: DSM IP ASSETS B.V.
Reel/Frame 052713/0877 →
Cited By (2)
US 12,187,852 US 12,428,514